Enanta Pharmaceuticals, Inc. (ENTA)
13.60
-0.20
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
13.58
-0.02
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Total Assets (Quarterly) : 296.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 296.87M |
| March 31, 2026 | 314.70M |
| December 31, 2025 | 329.50M |
| September 30, 2025 | 292.72M |
| June 30, 2025 | 301.03M |
| March 31, 2025 | 322.99M |
| December 31, 2024 | 348.64M |
| September 30, 2024 | 390.80M |
| June 30, 2024 | 398.82M |
| March 31, 2024 | 413.56M |
| December 31, 2023 | 428.50M |
| September 30, 2023 | 469.84M |
| June 30, 2023 | 495.17M |
| March 31, 2023 | 326.44M |
| December 31, 2022 | 347.53M |
| September 30, 2022 | 380.59M |
| June 30, 2022 | 385.21M |
| March 31, 2022 | 406.82M |
| December 31, 2021 | 440.59M |
| September 30, 2021 | 440.86M |
| June 30, 2021 | 450.44M |
| March 31, 2021 | 467.77M |
| December 31, 2020 | 481.01M |
| September 30, 2020 | 490.79M |
| June 30, 2020 | 511.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 513.50M |
| December 31, 2019 | 510.97M |
| September 30, 2019 | 491.04M |
| June 30, 2019 | 473.48M |
| March 31, 2019 | 461.58M |
| December 31, 2018 | 454.22M |
| September 30, 2018 | 415.17M |
| June 30, 2018 | 379.08M |
| March 31, 2018 | 354.65M |
| December 31, 2017 | 340.72M |
| September 30, 2017 | 327.85M |
| June 30, 2017 | 275.84M |
| March 31, 2017 | 278.96M |
| December 31, 2016 | 278.38M |
| September 30, 2016 | 281.36M |
| June 30, 2016 | 281.93M |
| March 31, 2016 | 281.60M |
| December 31, 2015 | 278.38M |
| September 30, 2015 | 246.01M |
| June 30, 2015 | 237.77M |
| March 31, 2015 | 245.88M |
| December 31, 2014 | 215.43M |
| September 30, 2014 | 155.42M |
| June 30, 2014 | 159.51M |
| March 31, 2014 | 108.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 392.02M |
| AbbVie, Inc. | 135.12B |
| Coherus Oncology, Inc. | 191.18M |
| BridgeBio Pharma, Inc. | 1.217B |
| RenovoRx, Inc. | 11.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 195.80M |
| Shareholders Equity (Quarterly) | 101.07M |
| Debt to Equity Ratio | 1.801 |
| Current Ratio | 3.759 |
| Net Debt Paydown Yield | 1.61% |